Shares of Repros Therapeutics Inc. (RPRX) were up over 30% in extended trading on Wednesday, following positive results from a phase 2b study of oral Proellex in women with severe menstrual bleeding due to uterine fibroids.
Forex – financial instrument.Forex news
Shares of Repros Therapeutics Inc. (RPRX) were up over 30% in extended trading on Wednesday, following positive results from a phase 2b study of oral Proellex in women with severe menstrual bleeding due to uterine fibroids.